Ertaczo (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Ertaczo drug offered from Valeant Pharmaceuticals North America LLC. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | Sertaconazole Nitrate |
SUBSTANCE NAME: | SERTACONAZOLE NITRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-12-10 |
END MARKETING DATE: | 0000-00-00 |
Ertaczo HUMAN PRESCRIPTION DRUG Details:
Item Description | Ertaczo from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/g) |
START MARKETING DATE: | 2003-12-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-5115_152e65eb-3bdb-4062-9c3f-168f3806b51d |
PRODUCT NDC: | 0187-5115 |
APPLICATION NUMBER: | NDA021385 |
Other SERTACONAZOLE NITRATE Pharmaceutical Manufacturers / Labelers: